Clinical Trials on Community Health Workers in New Zealand

Total 7998 results

University of Rochester

Completed

Uroflow Measurements in Healthy Volunteers

Healthy

United States
Pfizer

Completed

A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01)

Healthy

United States
Pfizer

Completed

Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation

Healthy

United States
Bausch & Lomb Incorporated

Completed

Corneal Endothelial Cell Density Changes In Healthy Subjects, When Administered ISV-403 for 5 Days

Healthy

United States
Pfizer
Yale University

Completed

Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects

Healthy

United States
Pfizer

Completed

Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532

Healthy

United States
Pfizer
Incyte Corporation

Completed

A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers

Healthy

United States
InLight Solutions
Luminous Medical

Completed

Near-Infrared Spectroscopy for Blood Glucose Measurements

Healthy

United States
Azevan Pharmaceuticals

Completed

Study of SRX246 Capsules in Healthy Adult Volunteers (AVN005)

Healthy

United States
Centers for Disease Control and Prevention
University of New Mexico

Completed

Computerized Risk Assessment in an Employee Population

Healthy

United States
Yale University

Terminated

Impact of Oral Contraceptives on GABA and Neurosteroids

Healthy

United States
Azevan Pharmaceuticals

Completed

Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers

Healthy

United States
Bristol-Myers Squibb

Completed

Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects

Healthy Adult Normals

United States
Sanofi

Completed

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)

Deep Venous Thrombosis

France, Mexico, Turkey, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Israel, Netherlands, New Zealand, Poland, Russian Federation, South Africa, Spain
Foresee Pharmaceuticals Co., Ltd.
InClin, Inc.

Not yet recruiting

Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers

Healthy

Australia
Pfizer
Arvinas Estrogen Receptor, Inc.

Recruiting

A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant

Healthy

United States
State University of New York - Upstate Medical...

Recruiting

Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software

Healthy

United States
Pfizer

Completed

A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.

Healthy

United States
Rutgers, The State University of New Jersey

Completed

Motivations to Transplant Registry Participation

Healthy

United States
Pfizer

Completed

A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.

Healthy

United States
Pfizer

Completed

A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants

Healthy

United States
Pfizer

Completed

A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955

Healthy

United States
Topcon Medical Systems, Inc.

Completed

TopQ Cut-Off Determination Study

Healthy

United States
Shire

Completed

A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers

Healthy

United States
Shire

Completed

A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers

Healthy

United States
Pfizer

Completed

A Study to Determine the Bioequivalence of Two Doses of Tafamidis

Healthy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers

Healthy

United States
Pfizer

Completed

A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations

Healthy

United States
NewLink Genetics Corporation

Completed

Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers (NLG2111)

Healthy

United States
Pfizer

Completed

A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS

Healthy

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Does Sweet Taste Potentiate Nicotine Cue Reactivity? (FNC-nicotine)

Healthy

United States
Pfizer

Completed

Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274

Healthy

United States
Pfizer

Completed

Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects

Healthy

United States
State University of New York at Buffalo

Completed

Metabolic Effects of Olanzapine in Healthy Males

Healthy

United States
Pfizer

Completed

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

Healthy

United States
Pfizer

Withdrawn

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

Healthy

United States
University of Pennsylvania

Completed

Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women

Healthy

United States
Northwell Health

Completed

Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers

Healthy

United States
Erydel

Completed

Recovery and Survival of EryDex in Non-patient Volunteers

Healthy

United States
Garden State Infectious Disease Associates, PA
GlaxoSmithKline

Completed

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

Healthy

United States
Pfizer

Completed

A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers

Healthy

United States
Arbor Pharmaceuticals, Inc.

Completed

A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers

Healthy

United States
Pfizer

Completed

A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

Healthy

United States
Pfizer

Completed

A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers

Healthy

United States
FORUM Pharmaceuticals Inc

Completed

Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308

Healthy

United States
Pfizer

Completed

A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865

Healthy

United States
Pfizer

Completed

A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects

Healthy

United States
Pfizer

Completed

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

Healthy

United States
Pfizer

Completed

A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562

Healthy

United States

3

Subscribe